Gyre Therapeutics Inc. (GYRE) stock news · rev $116.6M
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
This GYRE news page leads with what Gyre Therapeutics Inc. filed — not a scraped headline mill.
No cached 8-K sentence for GYRE yet. We will not pad this page with generic market recap.
Latest reported GYRE revenue for 2025-12-31 was $116.6M. Net income was $9.9M. Revenue was up 10.2% from 2024-12-31 to 2025-12-31. GYRE currently screens at market cap $589.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the GYRE stock page; for the tape open the quote page.
GYRE stock news FAQ
What are GYRE's latest revenue and net income?
Latest cached Gyre Therapeutics Inc. (GYRE) revenue for Dec 31, 2025 was $116.6M. Net income was $9.9M. Statements: https://lician.com/financials/gyre
How did GYRE revenue change from the prior cached period?
Cached Gyre Therapeutics Inc. (GYRE) revenue was up 10.2% from $105.8M (Dec 31, 2024) to $116.6M (Dec 31, 2025). Statements: https://lician.com/financials/gyre
What is GYRE's market cap?
Gyre Therapeutics Inc. (GYRE) market cap is $589.9M on the latest cached fundamentals snapshot.
What kind of company is GYRE?
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Where is GYRE stock news listed?
Cached stock news for Gyre Therapeutics Inc. (GYRE) is listed at https://lician.com/news/gyre. Filings: https://lician.com/sec/gyre
Not investment advice.